BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2754908)

  • 1. [Study of the changes in protein-lipid components of blood lipoproteins and the dynamics of coronary arteriosclerosis based on repeated angiographic examination].
    Nechaev AS; Gratsianskiĭ NA; Olfer'ev AM; Metel'skaia VA; Mazaev VP
    Kardiologiia; 1989 Apr; 29(4):16-21. PubMed ID: 2754908
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of changes in the protein-lipid components of blood lipoproteins and the dynamics of coronary arteriosclerosis based on repeated angiographic examinations].
    Nechaev AS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(1):93. PubMed ID: 2742772
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipoproteins and apolipoproteins in the young and familial risk of coronary atherosclerosis.
    Uiterwaal CS; Witteman JC; van Stiphout WA; Krauss XH; de Bruijn AM; Hofman A; Grobbee DE
    Atherosclerosis; 1996 May; 122(2):235-44. PubMed ID: 8769686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the levels and composition of lipoproteins and apolipoproteins of blood plasma in patients with ischemic heart disease after hemosorption].
    Torkhovskaia TI; Khalilov EM; Oleĭnik IA; Kliuchnikova ZhI; Klimov AN
    Kardiologiia; 1989 Oct; 29(10):60-4. PubMed ID: 2615161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between endogenous sex hormone levels, lipoproteins and coronary atherosclerosis in men undergoing coronary angiography.
    Kabakci G; Yildirir A; Can I; Unsal I; Erbas B
    Cardiology; 1999; 92(4):221-5. PubMed ID: 10844380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoproteins, apolipoproteins and coronary artery disease.
    Fruchart JC; Parra H; Cachera C; Clavey V; Bertrand M
    Ric Clin Lab; 1982; 12(1):101-6. PubMed ID: 6806881
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlations between intravenous fat tolerance and serum lipoproteins in normal and atherosclerotic subjects.
    Ericsson M; Rössner S
    Atherosclerosis; 1979 May; 33(1):89-97. PubMed ID: 223603
    [No Abstract]   [Full Text] [Related]  

  • 8. [Value of the analysis of lipoproteins after myocardial infarction].
    Dewailly P; Mellin D; Moulin S; Rouget JP; Sezille G; Jaillard J
    Presse Med; 1983 Jul 9-16; 12(29):1807-10. PubMed ID: 6224195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipoproteins, apolipoproteins and intravenous fat tolerance in young athletes.
    Ericsson M; Johnson O; Tollin C; Furberg B; Backman C; Angquist K
    Scand J Rehabil Med; 1982; 14(4):209-12. PubMed ID: 7178868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the clinical biochemistry laboratory in the assessment of dyslipoproteinaemias.
    Ballantyne FC
    Ann Clin Biochem; 1984 May; 21 ( Pt 3)():166-75. PubMed ID: 6383181
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum lipoproteins and coronary artery disease (CAD). Comparison of the lipoprotein profile with the results of coronary angiography.
    Wieland H; Seidel D; Wiegand V; Kreuzer H
    Atherosclerosis; 1980 Jun; 36(2):269-80. PubMed ID: 7406954
    [No Abstract]   [Full Text] [Related]  

  • 12. Laboratory parameters as discriminators for peripheral atherosclerosis and stroke.
    Kostner GM; Marth E; Pfeiffer KH; Wege H
    Monogr Atheroscler; 1986; 14():119-23. PubMed ID: 3736549
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lipoprotein spectrum and makeup of the individual classes in coronary arteriosclerosis with a varying lipid level in the blood plasma].
    Gasilin VS; Kurdanov KhA; Perova NV; Torkhovskaia TI; Gadzhalova SI
    Kardiologiia; 1980 May; 20(5):42-6. PubMed ID: 7392382
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum lipoproteins and apolipoproteins A I and A II in male patients with peripheral arterial insufficiency.
    Angquist KA; Johnson O; Ericsson M; Tollin C
    Acta Chir Scand; 1982; 148(8):675-8. PubMed ID: 6820598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipid metabolism disorders in patients with retinal artery occlusions].
    Fellinger C; Schmut O; Hofmann H
    Klin Monbl Augenheilkd; 1984 Feb; 184(2):109-11. PubMed ID: 6716886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemical indicators of coronary arteriosclerosis].
    Witkowska M; Dutkiewicz R; Karolko B
    Kardiol Pol; 1991; 35(11):275-82. PubMed ID: 1800821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of serum HDL phospholipid levels in angiographically defined coronary artery disease.
    Piperi C; Kalofoutis C; Papaevaggeliou D; Papapanagiotou A; Lekakis J; Kalofoutis A
    Clin Biochem; 2004 May; 37(5):377-81. PubMed ID: 15087253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Various lipoprotein fractions and their relation to ischemic heart disease].
    Palazzuoli V; Mondillo S; Kristodhullu A; De Stefano R; Amatucci G
    G Ital Cardiol; 1983; 13(2):90-4. PubMed ID: 6884650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Apolipoproteins - an important diagnostic indicator in the evaluation of coronary disease risk].
    Naruszewicz M; Nowicka G
    Pol Arch Med Wewn; 1980 Aug; 64(2):161-6. PubMed ID: 7433154
    [No Abstract]   [Full Text] [Related]  

  • 20. A study of serum lipoproteins and angiographic evidence of coronary artery disease.
    Berenson GS; Turner M; O'Meallie LP; Puyau FA; Pargaonkar PS; Srinivasan S; Hall RJ
    South Med J; 1975 Dec; 68(12):1513-9. PubMed ID: 173025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.